PLRX
Pliant Therapeutics, Inc.
$1.14
-0.03 (-2.56%)
At close · Jul 8
Market Cap
$70.59M
Shares
61,920,249
Price & Indicators
Indicators
Price
Panels
Event markers
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$1.14
Open$1.17
Day$1.13–1.18
52W$1.09–1.95
Avg vol 30d442K
Short int2.8M · 4.5% float · 5.2d
Short vol52%
Last earningsMay 11, 2026
DataJun 2020–Jul 2026
Filing10-Q · May 11
Equibles Rating
blended score · not investment advice
Overall
Sell
SellHoldBuy
Technical
Sell
Momentum
Very Weak
Sentiment
Neutral
Fundamentals
Strong
Quant / Vol
Very High
Market backdrop
VIX 16.9 · calm
Equity put/call 0.86
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−14%
below
Price vs 50-day avg
−3%
below
RSI (14)
46
neutral
MACD trend
Positive
52-week position
6%
near low
Momentum
relative strength
1-month return
−1%
trailing
6-month return
−12%
trailing
YTD return
−7%
this year
Relative strength
−19%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $1 › 200d $1 — 200d above 50d
Institutional flow
Distributing
-7% holders QoQ · +13 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
4.55% of float · ▼ -18.0% MoM · 5.2 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr low
90 holders — near 3-yr low, contrarian setup
Squeeze score
70
elevated · 0–100
Fundamentals
EPS growth
+30%
Y/Y
Free cash flow
$-128.7M
Balance sheet
$45.4M
net cash
Quant / Vol
risk profile
Volatility
58%
annualized · 1-yr
Max drawdown
−42%
past year
ATR
4.0%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Up next
Next earnings call
Aug 15, 2026
Est · unconfirmed
· in 5 wks
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed May 11, 2026
Technicals
trend & momentum for long-term holders Sell
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−14%
Bearish
Price vs 50-day avg
−3%
Neutral
RSI (14)
46
Neutral
MACD trend
Positive
Bullish
52-week position
6%
Bearish
Market signals — smart money & positioning
Mixed
Trend (MA cross)
No cross
50d $1 › 200d $1 — 200d above 50d
Institutional flow
Distributing
-7% holders QoQ · +13 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
4.55% of float · ▼ -18.0% MoM · 5.2 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr low
90 holders — near 3-yr low, contrarian setup
Price context
position in its 52-week range
52-wk low $1
Now $1 · 6%
52-wk high $2
vs 200-day avg -14%
vs 50-day avg -3%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
PLRX
this stock
Pliant Therapeutics, Inc.
|
$70.59M | -6.6% | — | — | 4.5% |
|
ONC
BeOne Medicines Ltd.
|
$446.53B | +1.7% | +22179.2% | 908.7 | 0.1% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$132.55B | +15.2% | +46.2% | 31.0 | 1.8% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$70.90B | -12.3% | +20.8% | 16.5 | 3.2% |
|
ARGX
Argenx SE
|
$57.49B | +9.4% | — | — | 2.4% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Financials
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| PLRX | +0.0% | -0.9% | -11.6% | +0.0% | -6.6% |
| SPY | +0.9% | +1.4% | +7.6% | +0.1% | +9.7% |
| vs SPY | -0.9% | -2.3% | -19.2% | -0.1% | -16.2% |